Targeted therapies in oncology come of age

Clin Ther. 2013 Sep;35(9):1256-7. doi: 10.1016/j.clinthera.2013.08.006.

Author

Andreas Klein¹

Affiliation

¹ Division of Hematology/Oncology Tufts Medical Center Boston, Massachusetts.

PMID: 24054702
DOI: 10.1016/j.clinthera.2013.08.006

No abstract available

Publication types

Editorial
Introductory Journal Article

MeSH terms

Antineoplastic Agents / pharmacology
Antineoplastic Agents / therapeutic use*
Drug Industry
ErbB Receptors / antagonists & inhibitors
ErbB Receptors / genetics
Humans
Molecular Targeted Therapy / economics
Molecular Targeted Therapy / methods*
Neoplasms / drug therapy*
Reproducibility of Results
Signal Transduction / drug effects
Signal Transduction / genetics
United States
United States Food and Drug Administration

Substances

Antineoplastic Agents
ErbB Receptors